Lightning Biotherapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Lightning Biotherapeutics General Information

Description

Developer of immunological therapeutic systems designed for the restoration of immune function. The company is currently operating in Stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Boston, MA
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Boston, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lightning Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Mar-2026 Completed Stealth
1. Accelerator/Incubator Completed Stealth
To view Lightning Biotherapeutics’s complete valuation and funding history, request access »

Lightning Biotherapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eos BioInnovation VC-Backed Company Minority
NYBC Ventures Corporate Venture Capital Minority
Panacea Capital (California) Venture Capital Minority
Harvard Innovation Launch Lab Accelerator/Incubator
To view Lightning Biotherapeutics’s complete investors history, request access »

Lightning Biotherapeutics FAQs

  • Where is Lightning Biotherapeutics headquartered?

    Lightning Biotherapeutics is headquartered in Boston, MA.

  • What industry is Lightning Biotherapeutics in?

    Lightning Biotherapeutics’s primary industry is Biotechnology.

  • Is Lightning Biotherapeutics a private or public company?

    Lightning Biotherapeutics is a Private company.

  • What is Lightning Biotherapeutics’s current revenue?

    The current revenue for Lightning Biotherapeutics is .

  • Who are Lightning Biotherapeutics’s investors?

    Eos BioInnovation, NYBC Ventures, Panacea Capital (California), and Harvard Innovation Launch Lab have invested in Lightning Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process